Automated Bispecific T-Cell Engager (BiTE) Foundry Cleanroom Cap Rate 2026

Underwrite GMP Class A/B continuous perfusion biomanufacturing suites producing bispecific antibody constructs and T-cell engager immuno-oncology biologics, $460/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

BiTE Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP BiTE Facility Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation